Fatigue is a key prognostic indicator for adverse outcomes in AML, ALL, and myelodysplastic syndromes. CAR T-cell therapy ...

Type 2 inflammation influences the severity of post-acute sequelae of SARS-CoV-2, highlighting the need for targeted ...

This year’s top diabetes content focused on pediatric metabolic health, misconceptions about weight loss drugs, and more.

The American Society of Hematology is launching health equity effort, "Treating Fairly," which was discussed at the quality ...

The Community Oncology Alliance (COA) meetings featured expert discussions around the evolving landscape of oncology care and ...

The mean body mass index (BMI) and the prevalence of obesity both dropped in 2023 for the first time in more than a decade.

Connect 2024 emphasized the transformative potential of artificial intelligence (AI) and predictive analytics in addressing ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

Results of a small study presented at the 66th American Society of Hematology Annual Meeting & Exposition suggest combining ...

Robin Glasgow, MBA, executive leadership advisor of Spencer Stuart, discusses the critical role of data in health care, ...

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage ...